Overview

The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules

Status:
Completed
Trial end date:
2018-11-29
Target enrollment:
Participant gender:
Summary
The Safety, Antiviral Activity, and pharmacokinetics of Morphothiadine Mesilate Capsules/Ritonavir Tablets in Patients with Chronic Hepatitis B
Phase:
Phase 2
Details
Lead Sponsor:
Sunshine Lake Pharma Co., Ltd.
Treatments:
Antiviral Agents
Ritonavir